Buy, Sell, Hold: 3 stocks are in focus on February 23, 2018

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Siemens

Brokerage: PhillipCap | Rating: Maintain Sell | Target: Cut to Rs 1,000

The global research firm said that the target includes value of special dividend of Rs 28 per share & net cash of Rs 211 per share. The stock is a long term negative as business opportunity shrinks for the listed company, it said, adding that mobility and mechanical drives business sale.

Brokerage: Deutsche Bank | Rating: Maintain Sell | Target: Rs 1,030

Deutsche Bank said that mobility separated just before the potential uptick. Meanwhile, it said that the stock is expensive on September FY19e P/E & EV/EBITDA Of 38.4x & 23.4x respectively. Valuations are steep for 26% PAT CAGR forecast over FY17-20.

Federal Bank

Brokerage: Jefferies | Rating: Buy | Target: Rs 145

Jefferies said that acquisition of minority stake (26%) in Equirus Capital augurs well. It observed that synergies lie in broadening product offerings to corporate & SME clients. Going forward, steady loan growth, & improvement in operating efficiency should increase profitability.

Ajanta Pharma

Brokerage: Motilal Oswal | Rating: Buy | Target: Rs 1,840

Motilal Oswal said that growth ingredients were in place. Rejigged strategies have started yielding results in Asia. Further, the company expects dermatology business to recover over the next 9-12 months. It also observed that the company is on track to outperform industry in other key therapies as well. It expects minimal regulatory hurdles over the medium-term for the US market.